BioCentury | Aug 27, 2019
Company News

Aug. 27 Company Quick Takes: GSK licenses Ionis HBV program; plus Adaptimmune-Noile, Purdue, Presage-BMS, Kyowa, Alexion, Viela, Kintai, OncoNano

...develop HPV candidate OncoNano Medicine Inc. (Southlake, Texas) received a $15.4 million grant from the Cancer Prevention and Research Institute of Texas...
BioCentury | Sep 21, 2018
Financial News

DePinho's STAT3 company Tvardi raises $9M series A

...company is seeking a CEO. Tvardi Therapeutics Inc., Houston, Texas Mary Romeo Alexandria Venture Investments Baylor College of Medicine Cancer Prevention and Research Institute of Texas...
BioCentury | Sep 20, 2018
Financial News

DePinho's STAT3 company Tvardi raises $9M series A

...consider an IPO or co-development partnership. The company is seeking a CEO. Mary Romeo Baylor College of Medicine Cancer Prevention and Research Institute of Texas...
BioCentury | Oct 5, 2015
Financial News

Mirna Therapeutics completes private placement

...placement Raised: $16.8 million Shares: 2.4 million Price: $7 Shares after offering: 20.1 million Investor: Cancer Prevention and Research Institute of Texas...
BioCentury | Oct 5, 2015
Financial News

Mirna Therapeutics completes IPO

...The shares after the offering figure includes the sale of 2.4 million shares to the Cancer Prevention and Research Institute of Texas...
BioCentury | Sep 28, 2015
Financial News

Mirna amends IPO

...amended its IPO on NASDAQ and now plans to sell 4.7 million shares at $13-$15. Cancer Prevention and Research Institute of Texas...
BioCentury | Sep 28, 2015
Company News

immatics, University of Texas MD Anderson Cancer Center cancer news

...Inc. has received $40 million from immatics and a grant for $19.7 million from the Cancer Prevention and Research Institute of Texas...
BioCentury | Sep 14, 2015
Financial News

Mirna amends IPO

...Oppenheimer; Cantor Fitzgerald Note: Mirna Therapeutics amended its IPO on NASDAQ and disclosed that the Cancer Prevention and Research Institute of Texas...
BioCentury | Feb 5, 2015
Finance

PPPs holding steady

...DNAtrix Inc.; Essa Pharma Inc.; ProNAi Therapeutics Inc.; ProPep Surgical LLC Baylor College of Medicine; Cancer Prevention and Research Institute of Texas...
BioCentury | Jul 24, 2014
Cover Story

It is an RNA world

...Private placement $14.1 million Feb. 24 ProNAi Cancer Prevention and Research Institute of Texas...
Items per page:
1 - 10 of 29
BioCentury | Aug 27, 2019
Company News

Aug. 27 Company Quick Takes: GSK licenses Ionis HBV program; plus Adaptimmune-Noile, Purdue, Presage-BMS, Kyowa, Alexion, Viela, Kintai, OncoNano

...develop HPV candidate OncoNano Medicine Inc. (Southlake, Texas) received a $15.4 million grant from the Cancer Prevention and Research Institute of Texas...
BioCentury | Sep 21, 2018
Financial News

DePinho's STAT3 company Tvardi raises $9M series A

...company is seeking a CEO. Tvardi Therapeutics Inc., Houston, Texas Mary Romeo Alexandria Venture Investments Baylor College of Medicine Cancer Prevention and Research Institute of Texas...
BioCentury | Sep 20, 2018
Financial News

DePinho's STAT3 company Tvardi raises $9M series A

...consider an IPO or co-development partnership. The company is seeking a CEO. Mary Romeo Baylor College of Medicine Cancer Prevention and Research Institute of Texas...
BioCentury | Oct 5, 2015
Financial News

Mirna Therapeutics completes private placement

...placement Raised: $16.8 million Shares: 2.4 million Price: $7 Shares after offering: 20.1 million Investor: Cancer Prevention and Research Institute of Texas...
BioCentury | Oct 5, 2015
Financial News

Mirna Therapeutics completes IPO

...The shares after the offering figure includes the sale of 2.4 million shares to the Cancer Prevention and Research Institute of Texas...
BioCentury | Sep 28, 2015
Financial News

Mirna amends IPO

...amended its IPO on NASDAQ and now plans to sell 4.7 million shares at $13-$15. Cancer Prevention and Research Institute of Texas...
BioCentury | Sep 28, 2015
Company News

immatics, University of Texas MD Anderson Cancer Center cancer news

...Inc. has received $40 million from immatics and a grant for $19.7 million from the Cancer Prevention and Research Institute of Texas...
BioCentury | Sep 14, 2015
Financial News

Mirna amends IPO

...Oppenheimer; Cantor Fitzgerald Note: Mirna Therapeutics amended its IPO on NASDAQ and disclosed that the Cancer Prevention and Research Institute of Texas...
BioCentury | Feb 5, 2015
Finance

PPPs holding steady

...DNAtrix Inc.; Essa Pharma Inc.; ProNAi Therapeutics Inc.; ProPep Surgical LLC Baylor College of Medicine; Cancer Prevention and Research Institute of Texas...
BioCentury | Jul 24, 2014
Cover Story

It is an RNA world

...Private placement $14.1 million Feb. 24 ProNAi Cancer Prevention and Research Institute of Texas...
Items per page:
1 - 10 of 29